Editorial orientation provided by MedAPI — not part of the coding instruction.
Malignant neoplasms of the lip most often arise from the vermilion or mucosal surface of the upper lip, lower lip, or oral commissure. The lower lip is affected more frequently, particularly with chronic ultraviolet exposure. Tobacco use, alcohol use, immunosuppression, chronic irritation, and precursor lesions such as actinic cheilitis may contribute to risk.
Common Histologies
- Squamous cell carcinoma is the predominant histology.
- Less common tumors include carcinomas arising from minor salivary glands of the inner lip and other rare epithelial malignancies.
- Malignant melanoma, Merkel cell carcinoma, and other skin cancers of the lip are classified outside C00.
Common Symptoms
- Persistent lip ulcer (K13.0), crust (K13.0), fissure (K13.0), plaque (K13.70), or nonhealing sore (K13.0)
- Firm nodule or area of induration (R22.9)
- Bleeding (R58), pain (R52), numbness (R20.0), or altered lip movement (R29.810)
- Difficulty eating (R63.30), speaking (R47.9), or maintaining oral competence (R13.11)
- Enlarged cervical or submental lymph nodes in regionally advanced disease (R59.0)
Diagnosis
Evaluation includes inspection and palpation of both external and inner lip surfaces, the commissures, oral cavity, and regional lymph nodes. Diagnosis requires biopsy with histopathologic confirmation. The pathology report may describe histologic type, grade, depth of invasion or tumor thickness, perineural or lymphovascular invasion, and margin status.
Cross-sectional imaging is generally reserved for larger, deeply invasive, recurrent, fixed, or clinically node-positive tumors. CT, MRI, ultrasound-guided nodal sampling, or PET/CT may be used according to disease extent.
Staging
Staging is based on the applicable contemporary TNM framework for the tumor’s exact anatomic epicenter and histology. Important features commonly include:
- Primary tumor size and depth or extent of invasion
- Involvement of adjacent skin, oral cavity, mandible, or other structures
- Regional nodal number, size, laterality, and extranodal extension
- Presence of distant metastasis
The appropriate staging framework may differ for mucosal lip tumors versus malignancies arising primarily in the cutaneous portion of the lip; the ICD-10-CM site code alone does not establish the staging system.
Molecular Markers
No single molecular marker is routinely required for all localized lip squamous cell carcinomas. Unlike oropharyngeal squamous cell carcinoma, p16 positivity is not by itself a validated surrogate for HPV-driven disease of the lip. In recurrent or metastatic disease, PD-L1 testing and broader molecular profiling may be considered when they could guide systemic therapy or clinical-trial selection.
Common Treatments
Treatment depends on subsite, size, depth, nodal risk, functional impact, and patient factors.
- Surgical excision with margin assessment is common for localized disease, often with reconstructive techniques to preserve oral competence and appearance.
- Radiation therapy may be used as definitive treatment in selected cases or postoperatively for adverse pathologic features.
- Regional nodal management, including sentinel node assessment, neck dissection, or nodal irradiation, may be considered for clinically involved nodes or sufficiently high-risk primary tumors.
- Combined-modality therapy may be required for locally advanced disease.
- Systemic therapy, including immune checkpoint inhibitors, platinum-based regimens, or other agents, may be used for unresectable, recurrent, or metastatic squamous cell carcinoma as clinically appropriate.
Scope Note
C00 identifies a primary malignant neoplasm of the lip and its coded subsite, such as external upper or lower lip, inner aspect, commissure, overlapping sites, or unspecified lip. It does not encode histologic type, grade, TNM stage, molecular findings, recurrence status, or treatment. It should not be used for malignant melanoma of the lip (C43.0), Merkel cell carcinoma of the lip (C4A.0), or other malignant neoplasms arising in the skin of the lip (C44.0-). Secondary or metastatic involvement of the lip is not classified as a primary C00 malignancy. Where documented, associated alcohol abuse or dependence and history of tobacco dependence may be represented with additional codes.